Skip to main content
. 2017 Nov 21;15(2):1566–1572. doi: 10.3892/ol.2017.7457

Figure 1.

Figure 1.

In vitro anticancer activities of 2 µM bufotalin and 4 µM bufalin. (A) Chemical structure of bufotalin and bufalin. (B) Cytotoxicity of bufotalin and bufalin towards human cancer and normal cells. The ESCC cells and Het-1A human esophageal squamous cells were treated with bufotalin and bufalin for 72 h, and the cell viability was examined by MTT assay.